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ORIGINAL ARTICLE
Comparative genomic analysis of two emergent human
adenovirus type 14 respiratory pathogen isolates in
China reveals similar yet divergent genomes
Qiwei Zhang1,2, Shuping Jing1, Zetao Cheng1, Zhiwu Yu3, Shoaleh Dehghan4,5, Amirhossein Shamsaddini5,
Yuqian Yan1, Min Li1 and Donald Seto5
Human adenovirus type 14 (HAdV-B14p) was originally identiﬁed as an acute respiratory disease (ARD) pathogen in The
Netherlands in 1955. For approximately ﬁfty years, few sporadic infections were observed. In 2005, HAdV-B14p1, a genomic
variant, re-emerged and was associated with several large ARD outbreaks across the U.S. and, subsequently, in Canada, the U.K.,
Ireland, and China. This strain was associated with an unusually higher fatality rate than previously reported for both this prototype
and other HAdV types in general. In China, HAdV-B14 was ﬁrst observed in 2010, when two unrelated HAdV-B14-associated ARD
cases were reported in Southern China (GZ01) and Northern China (BJ430), followed by three subsequent outbreaks. While
comparative genomic analysis, including indel analysis, shows that the three China isolates, with whole genome data available, are
similar to the de Wit prototype, all are divergent from the U.S. strain (303600; 2007). Although the genomes of strains GZ01 and
BJ430 are nearly identical, as per their genome type characterization and percent identities, they are subtly divergent in their
genome mutation patterns. These genomes indicate possibly two lineages of HAdV-B14 and independent introductions into China
from abroad, or subsequent divergence from one; CHN2012 likely represents a separate sub-lineage. Observations of these
simultaneously reported emergent strains in China add to the understanding of the circulation, epidemiology, and evolution of these
HAdV pathogens, as well as provide a foundation for developing effective vaccines and public health strategies, including nationwide
surveillance in anticipation of larger outbreaks with potentially higher fatality rates associated with HAdV-B14p1.
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INTRODUCTION
Adenoviruses are human pathogens, causing infections and diseases of
the respiratory, ocular, gastrointestinal, genitourinary, and metabolic
systems, including being linked to obesity.1 Interestingly, human
adenovirus (HAdV) isolates with highly similar genomes are associated
with sporadic and limited infections as well as with larger, wide-spread
outbreaks, particularly in environments with close-quartered and/or
vulnerable populations.2–14 In terms of public health, although HAdV
infections may be highly contagious, they are generally associated with
high morbidity rates rather than high mortality rates;13,15,16 therefore,
HAdVs do not command the attention shown to more deadly viral
pathogens such as HIV, Ebola virus, and SARS, and MERS corona-
viruses. However, in children and immunocompromised individuals,
particularly organ transplant recipients, HAdV infections may lead to
signiﬁcant rates of mortality.13,17–19
To date, applying high-resolution genomic and bioinformatic
approaches has yielded in-depth and clearer views of the natural
variation of HAdVs.9,12,14,20–37 In particular, the molecular evolution
and mechanisms of the genesis of emergent HAdV pathogens are
being revealed; for example, recombination appears to be a major
driving force14,20–23,25,26,29,38,39 and zoonosis has been revealed as the
origin for at least one important HAdV respiratory pathogen.36,37,40
Computational analysis of the genomes from these emergent HAdV
pathogens has led to laboratory-based experiments to explore con-
sequences of speciﬁc mutations and their roles in pathogenic proper-
ties;22,27,29,41 for example, examining the nonsynonymous mutation in
the ﬁber gene that potentially affects host receptor binding, which may
contribute to the robustness and altered pathogenic properties of the
re-emergent HAdV-14p1.41
More than 84 genotypes, including all previously characterized
serotypes, have been sequenced, characterized, and classiﬁed within
seven species A–G (http://hadvwg.gmu.edu/).21,24,28–31,42 Of these,
species B, C, and E viruses are associated with respiratory
diseases.17,43 Furthermore, species B HAdVs have been divided into
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subspecies B1 and B2, based on their genome similarities and
restriction enzyme digestion patterns,44 as well as reports of viruses
of these two subspecies showing different tissue tropism.45 Members
of subspecies B1, i.e., HAdV-B3, -B7, -B16, and -B21, are respiratory
pathogens, presumably due to their ability to infect cells of the
respiratory tract; HAdV-B50 is also a subspecies B1 virus but has not
been associated with a speciﬁc, if any, disease.46 Subspecies B2
comprises HAdV-B11, -B14, -B34, -B35, and -B55; of these, HAdV-
B11, -B34 and -B35 are recognized as renal or urinary tract
pathogens.17 The remaining two, HAdV-B14 and -B55, are respiratory
tract pathogens.2,14 HAdV-B55 is a ‘Trojan Horse’ recombinant with a
genome that is essentially that of a respiratory pathogen, HAdV-B14,
but with the serologic appearance of a renal pathogen.6–10,14 HAdV-
B14 was originally identiﬁed in a military trainee population as an
acute respiratory disease (ARD) pathogen in The Netherlands in
1955,2 with a second occurrence reported in a civilian setting in
England in the same year (1955).3 Since then and over the course of
approximately ﬁfty years, aside from a few sporadic and limited
infections, HAdV-B14 has rarely been reported.
Beginning in 2005, HAdV-B14 re-emerged in the U.S., with
multiple outbreaks in both civilian and military settings, as a highly
contagious respiratory pathogen that was associated with a 76%
hospitalization rate and an 18% fatality rate.47–49 This fatality rate
was alarming and unusual for a HAdV epidemic, particularly in
presumably otherwise healthy adults. The same genome type, HAdV-
B14p1, appeared in Europe with two ARD outbreaks in Ireland (2009)
and the U.K. (2011).5,11,50 These resulted in the highest fatality rates
reported for HAdV-B14 outbreaks, at 33% and 23%,
respectively.5,11,50 In 2011, this pathogen re-emerged in Canada and
caused one death in the three patients hospitalized with ARD.49 In
China, there were no HAdV-B14 cases reported until 2010, when
HAdV-B14 emerged nearly simultaneously in two geographically
distinct locations (Guangzhou and Beijing).12,32 Following these two
reports, at least three additional HAdV-B14-related ARD outbreaks in
China were recorded: One occurred in the Gansu Province (2011) in
which 43 students in an elementary school setting presented with
febrile respiratory illnesses,51 one occurred in Beijing (2012) in which
30 adults presented with severe symptoms that required
hospitalization,33 and the third occurred in Liaoning Province
(2012) in which 24 students in a middle school presented with febrile
respiratory illnesses.52 Unlike the U.S. 303600 strain, these ﬁve China
strains did not have fatalities associated with them.
Given the severity of the symptoms and the numbers of afﬂicted
individuals in China, the earlier outbreaks, with associated higher
morbidity and fatality rates in the U.S., Canada, and Europe, and the
putative transmission of HAdV-B14 from U.S. to Asia (South Korea)
by military trainees (2007),53 it is critical to determine the relation-
ships between these China isolates and their global counterparts in
order using high resolution genome analysis to understand the
epidemiology of this re-emergent pathogen. These data will provide
a basis for public health preventive measures, including diagnosis,
surveillance, and appropriate protocols for limiting outbreaks and
prevention. Speciﬁc information of the mutation rates, mutation
hotspots, and new variations, particularly at their serologic
recognition sites, will play a key role in the development of vaccines
against these pathogens. This report presents the bioinformatics
analysis of the HAdV-B14p1 Guangzhou strain (GZ01; October
2010), which was the ﬁrst HAdV-B14 strain isolated in China,12 and
compares it with the contemporaneous Beijing strain (BJ430; Decem-
ber 2010) as well as a subsequent strain isolated in 2012 (CHN2012;
February 2012). Provided is a high-resolution view of highly similar
yet intriguingly divergent genomes, linking one of these strains with
the globally re-emergent strain isolated in the U.S. in 2005, and
suggesting at least two co-circulating lineages of type 14.
MATERIALS AND METHODS
Cells, virus stock, and DNA preparation
HAdV-B14p1 GZ01was isolated from a throat swab of a 17-month-
old child hospitalized with acute suppurative tonsillitis in Guangzhou,
China (October 2010).12 Viral DNA was extracted using a Viral DNA
Extraction Kit (Omega Bio-Tek Inc Corp; Norcross, GA). The
protocol for PCR ampliﬁcation is described earlier.54 All the experi-
mental protocols in this study were approved by the institutional
ethics committee of Southern Medical University and were carried out
in accordance with the approved guidelines. The informed consent for
participation in this study was obtained from the guardian of the
under-aged participant. Data records of the sample and sample
collection are de-identiﬁed and completely anonymous.
Genome sequencing and annotation
The genome sequence of HAdV-B14p1 strain GZ01 was obtained
using the Sanger sequencing method following PCR ampliﬁcation of
targeted overlapping 1–2 kb regions that covered the entire genome, as
described earlier.12 The sequence data, collected with an ABI 3730
Genetic Analyzer, provided an average genome coverage of 3 to 5
folds, with both strands represented. Gaps and ambiguous sequences
were PCR-ampliﬁed using different primers and resequenced. DNA
sequence fragments were assembled using the SEQMAN software
from the Lasergene package (DNAStar; Madison, WI) into a single
contig. The genome was annotated with an annotation protocol used
for the HAdV-C1 genome analysis,35 by ﬁrst dividing the sequence
into contiguous 1 kb non-overlapping segments.
Sequence analysis
Comparison of sequence differences between and spanning the genomes
was performed with Genome Mutation Mapper (GMM; unpublished)
software developed by the authors. GMM compares two or more
genomes for nucleotide differences, noting SNPs and indels of query
genomes relative to a reference; the data were conﬁrmed with DNA
Sequencher v5.1 (GeneCodes, Inc.; Ann Arbor, MI). Additionally, pairs
of genome sequences were aligned using EMBOSS (http://www.ebi.ac.
uk/Tools/emboss/) to show sequence identity, which provided a
visualization of the alignment. Nucleic acid and amino acid sequence
percent identities were calculated using software which was part of the
EMBOSS package. Pair-wise comparisons of genomes were performed
with the LAGAN (Limited Area Global Alignment of Nucleotides)
program of mVISTA (http://genome.lbl.gov/vista/lagan/submit.shtml).55
Phylogenetic analysis of select genes and whole genomes was
performed using MEGA 5.1.0 (http://www.megasoftware.net/mega-
mac.php), which accepts FASTA ﬁles for sequence alignment and uses
a Maximum Composite Likelihood method that generated neighbor-
joining and bootstrapped phylogenetic trees with 1000 bootstrap
replications; for phylogenetic analysis; all other parameters were set
by default.
Genome type identiﬁcation
In silico restriction maps of available genome sequences from all
HAdV-14 strains CHN/GZ01/2010, 303600, CHN/BJ430, CHN2012,
and prototype de Wit were generated using the Vector NTI 10.3.0
software (Invitrogen Corp.; San Diego, CA, USA) as described in
earlier studies.56–58 These included proﬁles from restriction enzymes
BamHI, BclI, Bgll, BglII, BstEII, EcoRI, HindIII, HpaI, Sall, SmaI, XbaI,
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and XhoI (TaKaRa Corp.; China), all of which were chosen in order to
be consistent with the original nomenclature system devised by Li and
colleagues.59 Genome typing of these strains was determined by
comparing its in silico RE proﬁles with other HAdV-14 genome
types.4,34
GenBank accession numbers
The genome sequences used for phylogenic analyses are summarized
in Table 1, with additional genome typing details given only for the
type 14 strains (‘p’ denotes prototype; if no further designation is
noted, the strain is the prototype). Sequences used for these studies
included the E1A and hexon genes, either deposited as single gene
entries in GenBank or which were extracted from the genome ﬁles.
RESULTS
Nucleotide sequence analysis of HAdV-B14p1 strain GZ01
The genome of strain GZ01 was sequenced, assembled, annotated, and
analyzed using computational methods. Figure 1 presents the genomic
Table 1 The genome, ﬁber, hexon, and E1A sequences of adenovirus species A–G used in this study
Type Strain Year isolated Country Sequence GenBank accession no.
HAdV-A12 Huie 1954 USA Genome AC_000005
HAdV-B3 GB 1953 USA Genome AY599834
HAdV-B7 Gomen 1952 USA Genome AY594255
HAdV-B11p Slobitski 1956 USA Genome NC_011202
HAdV-B11a 273 1969 Spain E1A
Fiber
Hexon
FJ841916
FJ841908
FJ841900
HAdV-B11a 6380 1997 USA E1A
Fiber
Hexon
FJ841919
FJ841907
FJ841899
HAdV-B11a 2474 2001 Taiwan E1A
Fiber
Hexon
FJ841922
FJ841914
FJ841906
HAdV-B11a 760 2002 Taiwan E1A
Fiber
Hexon
FJ841921
FJ841913
FJ841905
HAdV-B11a RKI-2797-04 2004 Turkey Fiber
Hexon
AY972816
AY972815
HAdV-B11a SNG1222 2005 Singapore E1A
Fiber
Hexon
FJ841920
FJ841912
FJ841904
HAdV-B14p de Wit 1955 Netherlands Genome AY803294
HAdV-B14p 16845 1974 Netherlands E1A
Fiber
Hexon
FJ841917
FJ841910
FJ841902
HAdV-B14p1 2971 2007 USA E1A
Fiber
Hexon
FJ841915
FJ841909
FJ841901
HAdV-B14p1 Dublin 2009 Ireland Fiber
Hexon
HQ163916
HQ265808
HAdV-B14p1 303600 2007 USA Genome FJ822614
HAdV-B14p1 BJ430 2010 China Genome JN032132
HAdV-B14p1 GZ01 2010 China Genome JQ824845
HAdV-B14p1 CHN2012 2012 China Genome JX892927
HAdV-B14 Gansu2011-01 2011 China Hexon JX310315
HAdV-B16 ch.79 1955 USA Genome AY601636
HAdV-B21 AV-1645 1956 Saudi Arabia Genome AY601633
SAdV-21 Bertha 1954 USA Genome AC_000010
HAdV-B34p Compton 1972 USA Genome AY737797
HAdV-B35p Holden 1973 USA Genome AY128640
HAdV-B50 Wan 1988 USA Genome AY737798
HAdV-B55 QS-DLL 2006 China Genome FJ643676
HAdV-C1 Adenoid 71 1953 USA Genome AF534906
HAdV-D9 Hicks 1954 USA Genome AJ854486
HAdV-E4 RI-67 1952 USA Genome AY594253
HAdV-F40 Dugan 1979 Netherlands Genome NC_001454
HAdV-G52 T03-2244 2003 USA Genome DQ923122
The genome of HAdV-B14p1 GZ01 is shown in boldface.
Two emergent human adenovirus type 14 isolates
Q Zhang et al
3
Emerging Microbes & Infections
organization and transcription map of GZ01. A total of 38 coding
sequences were identiﬁed. These genome data were deposited in
GenBank (accession number JQ824845) under the formal name,
preferred by the National Center for Biotechnology Information
(NCBI),24 ‘Human adenovirus 14 isolate HAdV-B/CHN/GZ01/2010/
14[P14H14F14]’; in this report, it is shortened to ‘‘GZ01’’. The
genome comprises 34 767 bp, with a GC content of 48.83% that is
consistent with the other members of subspecies B2 (mean of 49%).60
A contemporaneous isolate BJ430 contains 34 762 bp.32 These lengths
are very similar to that of other HAdV-B14p1 strains 303600 (Lack-
land Air Force Base, USA; 2007) and CHN2012 (Beijing, China;
2012),33 as well as the prototype from 1955; Genome sizes of 34
763 bp, 34 760 bp, and 34 764 bp, respectively.
Genome type of strains GZ01, BJ430, and CHN2012 as HAdV-
B14p1
Genome type, based on restriction enzyme analysis (REA), was useful
in the past for characterizing strains in the absence of full genome
sequence data.59,61 It has limited use in the era of whole genome data,
but may be useful in comparisons with strains reported in the
literature with REA maps but are no longer available for futher
analysis. The genome types of strains GZ01, BJ430, and CHN2012
were determined by in silico REA using the Vector NTI 10.3.0 software
(Invitrogen Corp.; San Diego, CA, USA) and in comparison with the
other HAdV-B14 strains 4,34 (Figure 2). The REA proﬁles of GZ01,
BJ430, and CHN2012 were consistent with and indistinguishable from
that of HAdV-14p1 strain 303600, all which were conﬁrmed to be
genome type 14p1 according to the nomenclature published
previously.4,34 It is clear, however, that genome type analysis by
REA patterns may be misleading or incomplete as all the three China
isolates are highly divergent from HAdV-14p1, as demonstrated by the
indel mutations analysis. Furthermore, to support the observation that
genome type identiﬁcation may be misleading, it should be noted that
while the initial wet-bench REA data suggested 303600 was a novel
HAdV-B14a strain, it was disproven by the whole genome analysis.4,34
Inverted terminal repeat (ITR)
ITRs contain sequences encoding critical genome replication func-
tions. The HAdV-B14p1 GZ01 genome has a 137 bp ITR that is
identical to the ITRs of the other HAdV-B14p1 strains (BJ430,
CHN2012, and 303600), except for a C to G mutation at nt 134 of
strain CHN2012 (Figure 3). It is nearly identical to the ITRs reported
for the other subspecies B2 members. The ﬁrst 64 bases are completely
identical amongst the prototype subspecies B2 ITRs, which is different
for divergent subspecies B1. The binding sites for the host transcrip-
tion factors NF I and NF III were identiﬁed in the ITR.62,63 These
sequences have roles in enhancing virus replication and are necessary
for efﬁcient virus growth.62,63
Transcriptionally-related Sp1 and ATF binding sites were also
conserved in subspecies B2 genomes. All four HAdV-B14p1 genomes
differ from HAdV-B14p at position 68, with a C present, a transition
mutation from the original T; this is also found at the complementary
3'-end, a validation that it is not a sequencing error. This particular T
is conserved across all of the subspecies B2 prototypes, including
HAdV-B55, but not amongst all the prototypes of the other
subspecies, that is, all subspecies B1 members contain a C at this
position; this is a marker to distinguish B1 from B2, and also HAdV-
Figure 1 Genomic organization and transcription map of HAdV-B14p1 strain GZ01. The grey arrows indicate the early, intermediate, and late transcription
units; the red arrows indicate coding regions. Arrows reﬂect the direction of the coding transcripts.
Figure 2 Identiﬁcation of the genome types of HAdV-B14 strains GZ01 (Guangzhou), BJ430 (Beijing), and CHN2012 (Beijing). The in silico restriction
enzyme analysis (REA) digestion patterns of HAdV-14 genomes were generated using the Vector NTI 10.3.0 software (Invitrogen Corp., San Diego, CA, USA).
Genome digestion patterns of the strains are as follows: (A) de Wit or prototype (AY803294); (B) GZ01 (JQ824845); (C) 303600, reported as HAdV-B14p1
(FJ822614); (D) BJ430 (JN032132); and (E) CHN2012 (JX892927). These were analyzed with BamHI, BclI, Bgll, BglII, BstEII, EcoRI, HindIII, HpaI, SalI,
SmaI, XbaI, and XhoI, as described by Li et al.59 All the three recent China outbreak genomes correspond to the genome type of HAdV-14p1 and have
identical REA proﬁles to each other. They are divergent from the HAdV-B14 prototype (1955). M: 1 kb DNA Sizing Ladder.
Two emergent human adenovirus type 14 isolates
Q Zhang et al
4
Emerging Microbes & Infections
B14p1 from 14p. The nucleotide varies for the other six HAdV species
(data not shown).
Phylogenetic analysis of select genes and the whole genomes
Of the ﬁve recent China strains, only three were reported with whole
genome data (GZ01, BJ430, and CHN2012). Phylogenetic analysis of
the HAdV-B14 E1A, ﬁber, and hexon genes shows that the recent
HAdV-B14p1 strains (strains GZ01, BJ430, CHN2012, 303600, 2971,
and Dublin2009) are closely related to each other as well to the
prototype and earlier reported HAdV-B14p genomes (1955 and 1974),
as shown in Figure 4. The phylogenetic analysis of the whole genome
sequences also conﬁrms the sequence similarity with the prototype
genome after approximately 50 years and across large geographical
distances (Figure 4).
Distribution of indel mutations across the genomes
A global visualization of the alignment of genome sequences of GZ01,
BJ430, 303600, CHN2012, and de Wit prototype is presented in
Figure 5. This was generated using a ‘beta test version’ software,
Genome Mutation Mapper (GMM; unpublished) that notes SNPs and
indels of query genomes relative to a reference, and conﬁrmed using
DNA Sequencher (GeneCodes, Inc.; Ann Arbor, MI). The sequence
similarities amongst them indicates that although these HAdV-B14p1
viruses have a common ancestor (type 14 serotype), their insertion/
deletion (indel) patterns suggest two lineages. Indels and their
subsequently inherited conserved patterns across genomes are key
markers in determining lineages and for following molecular evolution,
as reversion is highly unlikely.64 Both strains GZ01 and BJ430 are
highly divergent from the U.S. strain 303600, with respect to the indel
Figure 3 HAdV-B Inverted terminal repeats (ITR) analysis. An alignment of the left ITRs of select HAdV-B prototypes is presented, with two sets of critical
sequence motifs (boxed): (1) Replication- Core origin, NF I and NF III binding sites, and (2) Sp1 and ATF binding sites. Nota bene, ‘.’ represent identical
bases and ‘-’ represent deletions or gapping for sequence alignment. HAdV-B1: HAdV-B3, -B7, -B16, -B21, and -B50; HAdV-B2: HAdV-B11, -B14, -B34,
-B35, and -B55.
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patterns; there is one indel distinguishing between GZ01 and BJ430, a
deletion at nt 29 481 in the BJ430 genome, that could be interpreted as
GZ01 being more similar to 303600. CHN2012 contains a divergent
indel pattern with respect to the other two China isolates. In addition
to three deletions in common, it contains two additional indels (one
each, insertion and deletion), relative to GZ01 and BJ430, that are
uniquely also in the prototype genome. This may be indicative of two
sub-lineages and independent introductions into China from abroad,
or subsequent divergence from one. The indel numbers and patterns
suggest there were at least two prototypes circulating in 1950s, time of
the ﬁrst prototype isolate, with one leading to 303600 and the second
leading to the cluster of recent China strains. This visualization of the
mutations alignment is critical to the understanding of the molecular
evolution and lineages of pathogens as the low resolution genome
percent nucleotide identities and REA (Figure 2) present very subtle
and limited differences. GZ01, BJ430, CHN2012, and 303600 have
highly similar percent identities in comparison with the prototype de
Wit at 99.646%, 99.666%, 99.684%, and 99.689%, respectively.
Figure 4 Phylogenetic analysis of the E1A, ﬁber, and hexon genes, as well as the whole genome sequences, from all HAdV-B14 strains and representatives
of other HAdV species. Nucleotide sequences of the E1A, ﬁber, and hexon genes, as well as limited whole genomes, are available from GenBank. Taxon
names include GenBank acc. no., isolation country, strain name, and year of isolation. Phylogenetic trees were generated by using the neighbor-joining
method with 1000 replicates and constructed by the MEGA 5.1.0 software (http://www.ebi.ac.uk/tools/mafft). In these analyses, default parameters were
applied, with a maximum-composite-likelihood model. Bootstrap numbers shown at the nodes indicate the percentages of 1000 replications producing the
clade, with values above 80 considered robust. The scale bar is in units of nucleotide substitutions per site. The China HAdV-B14 strains were indicated with
ﬁlled triangles.
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Base substitution analysis of type 14 strains GZ01, BJ430,
CHN2012, 303600, and de Wit
To complement and to check the global genome mutation map of the
alignments, each point mutation amongst the ﬁve genomes are noted
and compared, using the 2007 U.S. strain 303600 as reference
(Table 2). Base substitutions are indicative of recent and/or essential
mutations as reversion may occur, unlike indel mutations.64 The
whole genome sequence of strain GZ01 is very similar to that of strain
BJ430 with respect to mutations. Six mutation differences are noted
between these genomes. These SNPs include two non-synonymous
substitutions in the DNA polymerase (K to N) and protein VI genes
(R to K). Four synonymous substitutions are noted for the E1A 29.1 K
and 25.7 K genes, the L3 VI gene, and the E2A DNA binding protein
gene. One mutation is in a non-coding region (nt 225) and two
deletions, three T (nt 10 658) and one A (nt 13 266), in poly (T) and
poly (A) regions, are also noted (Table 2). Among these mutations, a
deletion of A at nt 29 481 in the BJ430 genome distinguishes it from
GZ01 (Figure 5).
When compared with strain 303600, 16 base substitutions were
found in 11 coding regions of GZ01, which resulted in three non-
synonymous substitutions in the E1A 6.5 K, E1B 54.9 K, and Protein
VI coding regions, respectively. All of the indels occurred in non-
coding regions, which led to length changes of the corresponding poly
(A) or poly(T) sequences. Compared with the prototype de Wit strain,
there were more mutations in strain GZ01, as would be expected given
the time differences between their isolations: 93 base substitutions in
the 31 genes, resulting in 35 non-synonymous substitutions. Although
there were nine indels involving 25 nucleotides, only two of these
resulted in non-synonymous substitutions: One in E1 29.1 K and
25.7 K coding regions (SV to I), with the other resulting the insertion
of two amino acids KE in ﬁber knob domain, which is the most
notable sequence difference between the HAdV-14p de Wit and all the
other HAdV-14p1 strains (Table 2). This was believed to have the
potential of altering cell receptor binding and tissue tropisms, and
hence pathogenicity, as the ﬁber knob recognizes the host cell
receptor.41
When compared with strain 303600, 11 base substitutions were
found in strain CHN2012, which resulted in two non-synonymous
substitutions in the E1B 54.9 K, E3 20.8 K coding regions, respectively.
There are four synonymous substitutions in the E2B/L1 43 K, hexon,
L4 100 K coding regions, respectively. The other mutations located at
NCR, including one C to G mutation in ITR.
DISCUSSION
China’s large, dense, and generally inaccessible population represents a
unique environment for studying viral pathogens once they enter the
population. The emergence, re-emergence, and transmission of a
particular pathogen may be followed using high-resolution genome
sequencing and, through computational methods, the molecular
evolution and epidemiology of the pathogen may be revealed in great
detail. According to the genome analysis of the three HAdV-B14
strains circulating in China, all three strains appear to be of separate,
but related, lineages and may likely have been transmitted from
abroad. Unlike the past, Beijing and Guangzhou are now ‘open’ to
unrestrictive global travel and this may situate them to be the foci for
the introduction of infectious disease agents to and from both overseas
and other China provinces. Uniquely, Guangzhou has four additional
direct long-standing connections to the international community.
First, since the mid-1800s, many China emigrants to overseas
destinations have originated from this region; therefore, there has
‘always’ been direct physical contact through homecoming visits.
Second, Guangzhou has hosted several international events recently,
bringing in an inﬂux of visitors. For example, the Asian Games (Nov.
2010) was hosted in Guangzhou, bringing in more than 14 000
athletes along with a large number of foreign tourists and regional
transient workers. Third, residents of other China provinces migrate to
this prosperous region. Finally, Guangzhou is only 119 km from Hong
Kong with the populations commingling; both populations are also in
close contact with the global community, including Americans from
both hemispheres, neighboring Asians, and Europeans, all of which
have experienced respiratory diseases linked to the subspecies B2
HAdVs as well as other respiratory pathogens. For instance, from 2002
Figure 5 Global genome mutation map visualization of the alignment of genomes from HAdV-14 strains de Wit, 303600, BJ430, GZ01, and CHN2012. To
assess the lineages and molecular evolution relationships of these pathogens, Genome Mutation Mapper (GMM; unpublished beta version) is used to provide
a global visualization of the nucleotide differences, including insertions and deletions (indels). The contemporaneously circulating and independently isolated
HAdV-B14p1 strains have divergent, yet similar mutation proﬁles, with the indels deﬁning their lineages. For this analysis, the genome of
HAdV-14p1_303600/USA/2007 is set as the reference to which the other genomes are compared. Query 1: HAdV-B14p_deWit/The Netherlands/1955
(prototype); Query 2: HAdV-B14p1_BJ430/China//2010; Query 3: HAdV-14p1_GZ01/China/2010; and Query 4: HAdV-B14p1_CHN2012/China/2012. The
triangles and inverted triangles indicate deletions and insertions, respectively; blue hash lines indicate base substitutions. Select gene markers are displayed
for reference (locations are approximate), as are the genome size markers noted along the bottom.
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to 2003, the severe acute respiratory syndrome coronavirus (SARS-
CoV) spread quickly from Guangzhou to Hong Kong and Beijing, and
then across the country and globally, with high morbidity and
mortality rates. Guangzhou, therefore, serves as an important focal
point for infectious disease pathogen introduction, and surveillance is
important in order to limit the public health impact on its population
and elsewhere in China.
HAdV are important pathogens that appear to re-emerge after
lengthy absences, either due to non-reporting because of diminished
pathogenicity and infectivity or to perhaps latency or other mechan-
isms of cryptic infection. HAdV-B14, for example, re-emerged after
approximately ﬁfty years and HAdV-B7d re-emerged after twenty-one
years.56 The 2005 re-emergent HAdV-B14p1 strain was associated
with several highly contagious and geographically wide-spread out-
breaks of ARD, and included unexpected higher rates of
fatalities.11,47,65 These outbreaks occurred in both civilian (24 com-
munities) and military (nine communities) populations in the United
States (2005–2009) and Europe (2009–2011).4,5,11,47,50,65 Parentheti-
cally and retrospectively, the ﬁrst case identiﬁed was in a child in
California (2003)4 and was presumably the originating point for the
subsequent larger military base outbreaks.65
In a limited retrospective survey of respiratory infectious disease
agents from patients at a hospital in Guangzhou (2010 and 2011),
HAdVs were found and characterized with respect to types.54 One of
these isolates, typed, deposited, and noted in GenBank as an emergent
and previously unreported HAdV type 14 in China (‘human adeno-
virus 14 isolate HAdV-B/CHN/GZ01/2010/14[P14H14F14’), was iso-
lated from a throat swab of a 17-month-old child with acute
suppurative tonsillitis (October 2010). Another simultaneously emer-
gent HAdV-B14 strain BJ430 was isolated from a six-month-old infant
diagnosed with bronchial pneumonia and hospitalized at the Beijing
Children’s Hospital (December 2010). This is unusual because this
condition had not been previously described for infections attributed
to either HAdV-B14 or HAdV-B55, with its similar genome and
disease symptoms.11,14,48,66 As HAdV-B14 has re-emerged globally
recently, and since it is known as a highly contagious pathogen that
has been associated with high hospitalization rates and fatality
rates,11,47,65 the emergence of this virus should set off an alarm that
the proper surveillance of this virus is critical for large dense
populations with naive immunity to HAdV-B14.
Comparative genomic analysis is leading to discovery of large
numbers of novel molecular markers that are proving very helpful
in understanding many important aspects of microbial phylogeny;67,68
of these molecular markers, the conserved indel mutations provide
particularly useful means for identifying different groups of microbes
in clear molecular terms and for understanding when they have
branched off from a common ancestor.67,69–71 As reported here, indel
mutations analysis suggests two co-circulating lineages from at least
two co-circulating ‘prototype’ strains in 1950s, one giving rise to the
303600 strain and the other giving rise to the China cluster of HAdV-
B14. Before the genomics era, many important adenovirus strains were
characterized by REA. REA is still useful for characterizing current
isolates by providing a bridge between their accessible genome data
and the REA data that are only available in the literature, as important
references and as historical isolates are no longer available for genomic
analysis.72 This report emphasizes that REA data should be carefully
considered, as it may be misleading and incorrect. Although the REA
analysis conﬁrmed strains GZ01, BJ430, and CHN2012 as belonging to
the same genome type 14p1 as strain 303600, high resolution analysis
of the genome sequences, including indels, indicate different lineages
and introductions into China, along with the absence of fatalities
associated with 303600. Again, based on the genome mutation
patterns, especially the indels, the de Wit prototype appears to be
very different from the 303600 and is similar to the BJ430, GZ01, and
CHN2012 strains. These may represent several lineages co-circulating
‘prototype 14’ strains, with one reported in the original study and the
rest accumulating characteristic indel patterns that have been reported
in this study. Most of the indels occur in the poly(A) and poly(T)
regions, which have been proposed as high-resolution molecular
strain markers for characterizing HAdV-14p1.71 The recent report
that HAdV-B14 dispersed from U.S. to Asia in 2007 via military
trainees53 provides another clue that the emergent HAdV-B14p1
strains in China may have been transmitted from abroad. However,
as shown in this report, the whole genome data of that strain is critical
for the correct interpretation of that possible transmission pattern.
The whole-genome sequences of strains GZ01 and BJ430 are nearly
identical with each other, with respect to point mutations. One indel
separates them. Strain GZ01 caused acute suppurative tonsillitis, an
upper respiratory disease; however, strain BJ430 was associated with
bronchial pneumonia, a lower respiratory tract disease. The reason for
this difference in pathogenicity may be due to the genomic differences.
A major difference between the two genomes is the two non-
synonymous substitutions in the DNA polymerase (K to N) and
protein VI genes (R to K), respectively (Table 2). Of these two
proteins, the 22-kDa cement protein VI is located beneath the
peripentonal hexons in the viral capsid. It is identiﬁed as an
endosomal membrane lytic factor, which is important for adeno-
viruses to overcome the barrier of the host cell membrane.73 The non-
synonymous substitution of R to K in the protein VI may lead to the
function of protein VI being enhanced or weakened, which can
presumably further change the HAdV tissue tropism. This is awaiting
wet-bench studies.
Given the current ease of travel and global interactions, these ARD
outbreaks associated with HAdV-B14 provide insights into the
distribution, lineage, and molecular evolution of this pathogen. There
had been no reports of HAdV-B14 in China prior to and during the
period noted for HAdV-B14 re-emergence and circulation (2005–
2009). This report presents the bioinformatics analysis of both HAdV-
B14p1 strains in high resolution and detail, and provides putative
lineages for these two surprisingly and intriguingly divergent, but,
highly similar genomes linking Guangzhou and Beijing (2294 kilo-
meters apart). A comparison with the re-emergent strain isolated in
the U.S. (2007) as well as with the less similar but still remarkably
conserved genome of the prototype virus from The Netherlands
(1955) is also presented. The presentation of high resolution nucleo-
tide sequence data and a map of mutations, particularly of the indels,
provide detailed insight into two contemporaneously circulating
human pathogens with divergent and parallel lineages. Both are noted
as genome type HAdV-B14p1 via their low resolution but conveni-
ently available REA patterns. The computational data presented in this
report again demonstrates highly conserved but divergent HAdV-B14
genomes, which supports further studies of the epidemiology and
molecular evolution of these related pathogens, and which, in turn,
will provide a foundation for developing effective vaccines and public
health strategies, including nationwide surveillance.
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